BeOne Medicines Ltd. Short-Term Debt 2017-2026 | ONC
Beta
What is short-term debt?
Short-term debt includes borrowings and the current portion of long-term debt due within one year.
What is BeOne Medicines Ltd.'s current short-term debt?
BeOne Medicines Ltd. (ONC) annual short-term debt for 2025 was $57.3M, a 93.27% decline from 2024. BeOne Medicines Ltd. short-term debt for the quarter ending March 31, 2026 was $116.1M.
What was BeOne Medicines Ltd.'s short-term debt in 2024?
BeOne Medicines Ltd. annual short-term debt for 2024 was $851.5M, a 23.70% increase from 2023.
What was BeOne Medicines Ltd.'s short-term debt in 2023?
BeOne Medicines Ltd. annual short-term debt for 2023 was $688.4M, a 109.25% increase from 2022.
What is BeOne Medicines Ltd.'s 5-year short-term debt CAGR?
BeOne Medicines Ltd. short-term debt grew at a compound annual growth rate (CAGR) of 29.76% from FY2020 to FY2025, going from $335.0M to $57.3M over 5 years.
Short-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-29.8%
FY2020
$335.0M
→
FY2025
$57.3M
171819202122232425
5 years selected
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →